Page 211 - Traité de Chimie Thérapeutique 4 Médicaments en relation avec des systèmes hormonaux

172 MÉDICAMENTS EN RELA DON A VEC DES SYSTÈMES HORMONA UX

Antilipolytiques
FULCHER R. et ALBERT! Hypoglycaemic action of antilipolytic agents in :
New antidiabetic drugs (BAILEY C.J. &. FLATT P. R edit.), Smith-Gordon, London,
1990, 143-155.
HOTTA N., KAKUTA H., FUKASAWA H„ KOH N, SAKAKIBARA F., KOMORIH. et
SAKAMOTO N., Effect of niceritrol on streptozotocin-induced diabetic neuropathy
in Rats, Diabètes, 1992, 41, 587-591.
Dérivés du vanadium

POSNER B.L, SHAVER A. et FANTUS G., Insulin mimetic agents : Vanadium and per-
oxovanadium compounds in : New antidiabetic drugs (BAILEY C.J. &. FLATT P. R
edit.), Smith-Gordon, London,1990,107-118.
GROS G., Pathophysiology and treatments of diabètes mellitus, Trends in Pharmacol.
Sci. 1990,11,34.
Mc NEILL J.H., YUEN V.G., HOVEIDA H.R., ORVIG C., Bis(maltolato)oxovanadium(IV)
is a potent insulin mimic. J. Med. Chem., 1992, 35,1489-1491.
SHECHTER Y. et SHISHEVA A., Vanadium salts and the future treatment of diabètes.
Endeavour New sériés, 1993,17, 27-31.
BORMAN S., Vanadium compounds may mimic oral insulin, Chemical & Engineering
news, 1994 (21 fév.), 35-36.
Amyline
EDWARDS B.J.A. et MORLEY J.E., Amylin, Lite science 1992, 51, 1899-1912.
RINK T.J., BEAUMONT K., KODA J. et YOUNG A., Structure and biology of amylin,
Trends in Pharmacol. Sci., 1993,14,113-118.